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Abstract
Background: Following antigen recognition, naive T helper (Th; CD4
+) cells can differentiate toward one of several
effector lineages such as Th1 and Th2; each expressing distinctive transcriptional profiles of cytokine genes. These
cytokines eventually instruct the strategy of the immune response. In our search for factors that propagate the
transcriptional programs of differentiated Th cells, we previously found that Polycomb group (PcG) proteins, which
are known as epigenetic regulators that maintain repressive chromatin states, bind differentially the signature
cytokine genes. Unexpectedly, their binding to the Ifng (Interferon-g) in Th1 cells and Il4 (Interleukin-4) in Th2 cells,
was correlated with transcriptional activation. Therefore, in this study we aimed to determine the functional role of
PcG proteins in the regulation of the expression of the signature cytokine genes.
Methods: PcG proteins were knocked down in primary and established murine Th cells using transduction of
lentiviruses encoding short hairpin RNAs (shRNAs) directed to Mel-18, Ezh2, Eed and Ring1A, representative of two
different PcG complexes. The chromatin structure and the binding activity of PcG proteins and transcription factors
at the Ifng promoter were assessed by chromatin immunoprecipitation (ChIP) assays.
Results: Downregulation of PcG proteins was consistent with their function as positive regulators of the signature
cytokine genes in primary and established Th1 and Th2 cells. Moreover, the PcG protein Mel-18 was necessary to
recruit the Th1-lineage specifying transcription factor T-bet, and the T cell receptor (TCR)-inducible transcription
factor NFAT1 to the Ifng promoter in Th1 cells. Nevertheless, our results suggest that PcG proteins can function
also as conventional transcriptional repressors in Th cells of their known target the Hoxa7 gene.
Conclusions: Our data support a model whereby the non-differentially expressed PcG proteins are recruited in a
Th-lineage specific manner to their target genes to enforce the maintenance of specific transcriptional programs as
transcriptional repressors or activators. Although our results suggest a direct effect of PcG proteins in the regulation
of cytokine gene expression, indirect functions cannot be excluded.
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Background
When naive Th cells encounter an antigen for the first
time, they can differentiate into the effector lineages
Th1, Th2 and Th17 that differentially express cytokine
genes [1-3]. The Th1 and Th2 lineages are characterized
by the expression of the signature cytokines IFNg and
IL-4, respectively. IFNg exerts protective functions in
microbial infections and is observed clinically in cases of
autoimmune diseases. IL-4 is strongly apparent in
parasitic infections, and is associated with allergic reac-
tions. The polarization of Th cells is most efficiently
promoted by the cytokine milieu; IL-12 strongly potenti-
ates the differentiation toward the Th1 lineage and IL-4
toward Th2. Although the activities of the polarizing
cytokines ultimately lead to distinct Th phenotypes, the
differentiation processes have similar features such as
the expression of lineage-specifying transcription factors.
The lineage-specifying transcription factors, T-bet in
Th1 and GATA3 in Th2 cells, function as master regu-
lators that establish the appropriate gene expression
profiles for one lineage and oppose the alternative fates.
Differential pattern of cytokine gene expression is also
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transcription factors such as NFAT [4]. All of these
activities are accompanied by major epigenetic changes
[1-3] that are probably involved in the heritability of the
transcriptional programs of differentiated Th cells. How-
ever, epigenetic regulation of Th cells preserves a certain
level of plasticity that may allow adaptation to new
immunological challenges [3,5-12].
Which factors are necessary to maintain the cellular
memory of differentiated Th lineages? Several studies
showed that the maintenance of the Ifng and Il4 tran-
scriptional patterns in Th cells is not mediated exclu-
sively by the lineage-specifying transcription factors
[13-17]. Therefore, the lineage-specifying transcription
factors may induce the expression of downstream speci-
fic factors or alternatively, facilitate restricted binding of
a generally expressed epigenetic machinery. We pre-
viously showed that PcG proteins, whose role in main-
taining gene silencing during embryogenesis is well
known [18-24], bind the cytokine genes [25]. However,
their binding activity was associated unconventionally
with gene expression not silencing; in each lineage they
were associated with the signature cytokine gene Ifng in
Th1 cells and Il4 in Th2 cells [25].
The PcG and trithorax group proteins were first iden-
tified in Drosophila, as transcriptional regulators of the
homeotic (Hox) genes during development. In contrast
to the PcG proteins, the trithorax group proteins were
characterized by their ability to maintain active tran-
scription. The PcG proteins form two major complexes,
PcG repressive complex 1 (PRC1), which contains the
core proteins M33, Bmi-1, Mel-18, Ring1A, and Ring1B,
and PRC2, with the core proteins Suz12, Ezh2, and Eed.
However, biochemical purification demonstrated a sig-
nificant variety in the content of these complexes
[21,24,26]. The mechanisms by which PcG proteins
mediate the epigenetic inheritance of transcriptional
silencing are not fully understood [27], but they are
known to be associated with histone modifications:
Ring1B is histone H2A ubiquitin E3 ligase, and Ezh2 is
histone methyltransferase that preferentially trimethy-
lates histone H3 on lysine 27 (H3K27me3). The function
of the PcG proteins also entails non-catalytic activities
[26,28-30], such as chromatin compensation, long-range
intrachromosomal interactions [31-35] and repression of
transcriptional elongation [36]. Genome-wide binding
profiles in Drosophila, murine and human embryonic
stem cells have demonstrated that the PcG proteins
have additional targets to the Hox genes, most of them
are transcriptional regulators of development [37-42].
These genes are predominantly inactive in embryonic
stem cells, and many are marked bivalently by both the
PcG repressive mark H3K27me3 and the trithorax
group permissive mark H3K4me3 [21,28,43]. Under this
status, premature differentiation is prevented, and the
pluripotency of the embryonic stem cells is maintained.
Developmental signals eventually induce or stably
silence the expression of these genes. The PcG proteins
are also crucial during hematopoiesis [24,44,45], and
their dysregulation has been linked with various human
cancers, apparently due to the altered transcription of
PcG-target genes that control cell proliferation and dif-
ferentiation [24,46].
Considering the known function of the PcG proteins
as transcriptional repressors, our previous results
demonstrating the binding pattern of PcG proteins at
the cytokine promoters in Th cells [25], raised the feasi-
ble scenario in which PcG proteins restrain overexpres-
sion of the active/accessible cytokine genes. However,
our knockdown experiments are more compatible with
the idea that the PcG proteins Mel-18, Ezh2, Eed and
Ring1A can function as transcriptional activators of Ifng
in Th1 and Il4 in Th2 cells, rather than transcriptional
repressors. Moreover, in Th1 cells, Mel-18 was required
for the recruitment of the crucial transcription factors
T-bet and NFAT1 to the Ifng promoter. Nevertheless,
our results also demonstrated that PcG proteins func-
tion as repressors of Hoxa7 in both Th1 and Th2
lineages, and of Tbx21 (which encodes T-bet) in Th2
cells. All together, our data propose a bi-functional role
for the PcG proteins in differentiated Th cells.
Methods
Ethic statement
The studies have been reviewed and approved by the
Inspection Committee on the Constitution of the Ani-
mal Experimentation at the Technion.
Mice
Female BALB/c mice were purchased from Harlan Bio-
tech, Israel, and maintained under pathogen-free condi-
tions in the animal facility of the Faculty of Medicine,
Technion-Israel Institute of Technology.
In vitro Th-cell differentiation and Th-cell lines
CD4
+ T cells were purified from the spleen and lymph
nodes of 3-4-week-old mice with magnetic beads
(Dynal). For Th differentiation, the cells were stimulated
with 1 μg/ml anti-CD3ε (to activate the TCR; 145.2C11,
hybridoma supernatant) and 1 μg/ml anti-CD28 (to acti-
vate co-stimulatory molecule; 37.51, BioLegend) in Dul-
becco’s modified Eagle’sm e d i u m( D M E M )
supplemented with 10% fetal calf serum, L-glutamine,
penicillin-streptomycin, nonessential amino acids,
sodium pyruvate, vitamins, HEPES and 2-mercaptoetha-
nol, in a flask coated with 0.3 mg/ml goat anti-hamster
antibodies (ICN). For Th1 differentiation, the cells were
stimulated in the presence of 10 ng/ml recombinant
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IL-4 antibodies (11B11). For Th2 differentiation, the
cells were stimulated in the presence of 1000 U/ml
mouse IL-4 (added as a supernatant of the 13L6 cell
line), 5 μg/ml purified anti-IFNg antibodies (XMG1.2),
and 3 μg/ml purified anti-IL-12 antibodies (C178). After
2 days, the medium was expanded (fourfold) in the
absence of anti-TCR or anti-CD28 antibodies, but in the
continued presence of cytokines and other antibodies,
which included 12 U/ml IL-2. The medium was then
expanded every other day. After 6 or 8 days, the differ-
entiated Th cells were left unstimulated or were resti-
mulated with either PMA (15 nM) and ionomycin (0.75
μM) (P+I) or with anti-CD3ε and anti-CD28 antibodies,
as indicated. When indicated, 2 μM Cyclosporine A
(CsA) was added 0.5 hour before stimulation. The mur-
ine Th1 cell clone D5 (Ar-5 [47]) and Th2 cell clone
D10 (D10.G4.1 [48]) were restimulated every 4-6 weeks
with antigen (arsonate-conjugated ovalbumin for D5,
and conalbumin for D10) in the presence of compatible
CAF1/J mouse splenocytes that had been irradiated with
2000 rads.
Chromatin Immunoprecipitation (ChIP)
The ChIP analysis was carried out as previously
described [25]. Quantitative PCR was performed using
Absolute Blue SYBR-Green ROX mix (Thermo Scienti-
fic, ABgene), according to the manufacturer’si n s t r u c -
tions, and an ABI Prism 7000 Sequence Detection
System (Applied Biosystems) or Corbett Rotor gene
6000 (Qiagen). The dissociation curves after amplifica-
tion showed that all the primer pairs generated single
products. The amount of PCR product amplified was
calculated relative to a standard curve of the input. The
following antibodies were used: anti-Mel-18 (Santa
Cruz; sc-8905), anti-ENX-1 (Ezh2, Santa Cruz; sc-17270
and 17268), anti-YY1 (Santa Cruz; sc-1703), anti-T-bet
(Santa Cruz; sc-21003), anti-trimethyl-Histone H3(Lys4)
(Upstate 07-473), anti-acetyl-Histone H3 (Upstate 06-
599), anti-H3K27 (Upstate 07-449), and rabbit anti-
NFAT1 (T2B1 and 67.1 [49]). The following primer sets
were used: Ifng Promoter: 5’-CTGTGCTGTG
CTCTGTGGAT-3’ and 5’-GTGCCATTCTTGTGG-
GATTC-3’. Il4 Promoter: 5’-CTCCTGGAAGAGAG
GTGCTG-3’ and 5’-GTTGCTGAAACCAAGGGAAA-
3’. Hoxa7 Exon 1: 5’-GCGGACAGGTTACAGAG -3’
and 5’-CCCCGACAACCTCATACC-3’. Tbx21P r o m o -
ter:5’-TTTCTCTCCCCGAGGAAGT-3’ and 5’-AGGCG
TGAGAATGCTCAG-3’. Gata3 distal promoter (1a):5’-
TGCCTATGATAATGGCCCATTC-3’ and 5’CTGCT
CCTGGTGCCTACAAAG-3`. Gata3 proximal promoter
(1b):5’-AAACGTTCTGGCTTGAATCCT-3’ and 5’AG
ATTATTCCGTACGAGTGA-3’.
RNA interference
The knockdown was accomplished with lentiviral
shRNA (MISSION, Sigma). The lentiviral particles were
produced by the calcium chloride-mediated transfection
of HEK-293T cells. The supernatants were collected 24
hours post-transfection for 8 hrs and used immediately
for transductions. For naïve Th-cell transduction, CD4+
cells were isolated and incubated in 6-well plates coated
with anti-hamster antibodies, viruses, polybrene (8 μg/
ml), and anti-CD3 and CD28 antibodies under skewing
conditions for 16-18 hours. The medium was then
replaced with fresh skewing medium, and 24 hours
later, the medium was replaced again with selection
medium, containing puromycin (8 μg/ml, Sigma) for 3
more days. The D5 and D10 cells were stimulated with
antigen and transduced 24 hours later with the lentiviral
particles for 16-18 hours, then the medium was replaced
with medium for selection (IL-2 and puromycin) for 2-5
weeks. The following shRNA sequences were used:
Ezh2; (Ez1) CGGCTCCTCTAACCATGTTTA, (Ez2)
CCGCAGAAGAACTGAAAGAAA, (Ez3) GCTAGGC
TAATTGGGACCAA. Mel-18; (M1) CGCTACTTGGA
GACCAACAAA, (M2) CAAAGTTCCTCCGCAACA
AA, (M3) ACCCTCTCCTTCCGCAGCCAT. Eed; (Ee1)
TCTTGCTAGTAAGGGCACATA, (Ee2) CGGCTATT
CGACAAACCAGTT, (Ee3) CCGGCCAGTGTGACA
TTTGGT. Ring1A; (R1) GCCTGGAAGGTGTCAG
CGA, (R2) GTACGTGAAGACTACTGGG, (R3) CACT
GACCTTGGAGCTTGT. Control scrambled shRNA;
CAACAAGATGAAGAGCACCAA.
RNA extraction and Real-time PCR
Total RNA was extracted, reverse-transcribed, and
amplified. Melt curves were run to ensure amplification
of a single product. The ratio between the transcripts
was calculated as:
(1) ΔΔCt = [(Ct(gene of interest) -Ct(b2m ) )PcG-(Ct(gene of
interest) -Ct(b2m ) )normalaizer]
(2) Fold increase = 2
- ΔΔCt
PcG refers to the results obtained with PcG shRNAs
as indicated and normalaizer with scrambled shRNA.
The following primer sets were used: Mel-18: 5’-AGCT-
GAACCCTCACCTCATGTG-3’ and 5’-TACGATG
CAGGTTTTGCAGAAG-3’. Ezh-2: 5’-AGTCGCCT
CGGTGCCTATAAT-3’ and 5’-AAAGTGCCATCCTGA
TCCAGA-3’. Eed:5 ’-ATCATAACCAGCCATTGT
TTGGA-3’ and 5’-GCAATAACCGTATCTCCCCCTG-
3’. Ring1A: 5’-CGCTGAATGGATCACTGACCT-3’ and
5’-CCCCTTGTGACATCATTTTGG-3’. Beta-2-micro-
globulin: 5’-TTCTGGTGCTTGTCTCACTGA-3’ and
5’CAGTATGTTCGGCTTCCCATTC-3’. Ifng: 5’-GCG
TCATTGAATCACACCTG-3’ and 5’TGAGCTCATT
GAATGCTTGG-3’. Tbx21: 5’-GGTGTCTGGGAAGCT
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Tnfa: 5’-CCAGACCCTCACACTCAGATCA-3’ and 5’-
CACTTGGTGGTTTGCTACGAC-3’. Il13: 5’-ACCCA
GAGGATATTGCATGGC-3’ and 5’-CGTGGCGAAA
CAGTTGCTTT-3’. Il4:5 ’-CCAAGGTGCTTCGCA
TATTT-3’ and 5’-ATCGAAAAGCCCGAAAGAGT -3’.
Il5: 5’-CACCAGCTATGCATTGGAGA-3’ and 5’-TC
CTCGCCACACTTCTCTTT-3’. Il10: 5’-CTGGACAA
CATACTGCTAACCG-3’ and 5’-GGGCATCACTTCTA
CCAGGTAA-3’. Rad-50: 5’-TGATAAGTTGTCTTG
GGGTTTCC-3’ and 5’-CTGTGTCTGACGCACCTGT-
3’. Hoxa7: 5’-GAAGCCAGTTTCCGCATCTA-3’ and 5’-
CGTCAGGTAGCGGTTGAAAT-3’. Noxa: 5’-CCCAC
TCCTGGGAAAGTACA-3’ and 5’- AAATCCCTTCAG
CCCTTGAT-3’. NFAT1: 5’-ACGGGAGTGACCGT-
CAAAC-3’ and 5’-CGGGAGGGAGGTCCTGAAA-3’.
Gata3(1a): 5’-GAGCGTCAGCAACAGTGAAG-3’ and
5’-CCACACTGCACACTGATTCC-3’. Gata3(1b): 5’-
CAATCTGACCGGGCAGGT-3’ and 5’-CAGAGACG
GTTGCTCTTCCG-3’
Western Blot Analysis
Total protein was extracted using a Norgen kit (Cat
23000) or cytosolic/nuclear extract preparation, and the
samples were separated by SDS polyacrylamide gel elec-
trophoresis, transferred to PVDF membranes, and
probed with anti-Ezh2 (612667, BD), anti-NFAT1 (67.1),
anti-GATA3 (Santa Cruz; sc-268), anti-T-bet (Santa
Cruz; sc-21003), anti-C-jun (Santa Cruz; sc-1694), or
anti-a-Tubulin (Sigma; T-9026) antibodies.
Flow Cytometry
Intracellular staining was performed using the BD Cyto-
fix/Cytoperm kit, according to the manufacturer’s
instructions. The cells were stained with anti-Mel-18
(sc-10744, Santa Cruz) antibodies.
Cytokine ELISA
The ELISA kits purchased from BioLegend were used.
Results
Mel-18 regulates transcriptional patterns in primary Th1
and Th2 cells
Since, as we have previously shown, Mel-18 binds the
Ifng promoter in Th1 cells and Il4 promoter in Th2
cells in association with gene expression [25], we wanted
to examine its functional role in the regulation of these
cytokine genes. Freshly isolated CD4
+ T cells (naive)
were stimulated under Th1- or Th2-skewing conditions;
Th1 cells expressed Ifng mRNA and Th2 cells expressed
Il4 mRNA after stimulation, indicating that the cells
were adequately differentiated and stimulated (data not
shown). Mel-18 mRNA level increased in differentiating
Th1 and Th2 cells, peaking on the second day (Figure
1A). The expression was basically unchanged following
re-stimulation with PMA and ionomycin (P+I), which
mimics TCR stimulation. Although the expression was
higher in Th2 than in Th1 cells, the pattern was similar,
supporting the idea that Mel-18 has parallel functions in
both lineages.
Naive cells were stimulated under Th1- or Th2-skew-
ing conditions, and simultaneously transduced with len-
tivirus encoding either one of two different shRNAs
directed to Mel-18 or a control scrambled sequence
(Figure 1B and 1C). In Th1 cells the level of Mel-18
mRNA was downregulated to ~35-45% (Figure 1B);
Mel-18 protein level was also reduced (Figure 1D).
Downregulation of Mel-18 resulted in a decreased
amount of Ifng mRNA (Figure 1B), as well as of IFNg
protein (Figure 1E), indicating that Mel-18 is a positive
regulator of Ifng. Robust expression of Ifng requires the
activity of transcription factors downstream to the TCR
and cytokine receptors. However, the decline in Ifng
expression probably did not result from changes in the
expression levels of the mRNA or protein of the Th1-
lineage specifying transcription factor T-bet, as these
levels were essentially unaffected (Figure 1B and 1F).
Similarly, the amounts of NFAT1 (NFATc2) mRNA and
protein were almost unchanged (Figure 1B and 1F). The
mRNA level of another cytokine Tnfa was also reduced,
as well as of Rad50, which is expressed in both Th1 and
Th2 cells from the Il4 locus. The expression of Noxa,
encoding a pro-apoptotic protein that is repressed in Th
cells by the PcG protein Bmi-1, [50], was almost
unchanged. In contrast, the expression of Hoxa7,a
known PcG target gene during development, which is
also involved in T-cell leukemia [51], was significantly
upregulated.
In Th2 cells, the expression of Mel-18 was knocked
down to ~20-40%, and consequently the amount of Il4
mRNA was reduced by half (Figure 1C). The decrease in
the levels of Mel-18 and IL-4 was confirmed (Figure 1D
and 1E). These results indicate that in Th2 cells, as in
Th1 cells, Mel-18 positively regulates the expression of
the hallmark cytokine gene. Mel-18 was also necessary
for the expression of Il10 and two other Th2 cytokine
genes that are expressed from the Il4 locus, Il5 and Il13
(the later was reduced significantly only with one of the
Mel-18 shRNAs). The levels of the two transcripts of
the Th2-lineage specifying transcription factor Gata3
(containing the alternative1 aa n d1 be x o n s[ 5 2 ] )w e r e
similar to the control, except that one of the shRNAs
led to a decreased Gata3(1a) level. We did observe a
reduced level of GATA3 protein (Figure 1F), thus it is
possible that Mel-18, like Bmi-1 [53], is involved in the
stabilization of GATA3. The mRNA amounts of
NFAT1, Rad-50, and Noxa were comparable to the con-
trol. However, the expression of Hoxa7 was increased
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Figure 1 Knockdown of Mel-18 downregulates the expression of cytokine genes in primary Th1 and Th2 cells. (A) Quantitative RT-PCR
for Mel-18 in naïve cells, differentiating Th1 and Th2 cells (days 2, 6, and 8), and 8
th-day differentiated Th1 and Th2 cells after 1 or 2 hours of re-
stimulation with P+I. The expression level in Th1 cells on day 2 was set as 1. (B,C) Quantitative RT-PCR for the indicated mRNAs following Mel-18
knockdown by Mel-18-directed shRNAs M1, M2 or control non-silencing scrambled shRNA during Th1 (B) and Th2 (C) differentiation. The results
are presented relative to the control, defined as 1. The cells were transduced on day 0, and after 3 days of puromycin selection, on the 5
th day,
they were re-stimulated with P+I for 2 hours. Differences between knockdown and control with p values ≤ 0.05 (Student’s t test) are indicated
with an asterisk. (D) Intracellular staining of Mel-18 in the indicated transduced Th1 and Th2 cells. (E) ELISA for the levels of IFNg and IL-4 in the
supernatants of 4-hour-stimulated (aCD3 and aCD28) Th1 and Th2 cells, respectively, after Mel-18 knockdown. The results with control shRNA
were set as 1. (F) Western blot assessing the indicated proteins on the 5
th day of Th1 and Th2 cell transduced with control shRNA [C] or shRNA
directed to Mel-18 [M1]. c-jun is used as loading control. (G) Quantitative RT-PCR for the indicated mRNAs after Mel-18 knockdown in Th1 (left)
and Th2 (right) cells as described in Figure 1B, except the cells were re-stimulated with aCD3 and aCD28 antibodies. Differences between
knockdown and control with p values ≤ 0.05 are indicated with an asterisk. The results in Figure 1 are the mean of two to five independent
experiments +S.D., except in panels 1D and 1F, which are representative experiments.
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cells.
Similar results demonstrating the positive regulation of
cytokine genes and negative regulation of Hoxa7 by Mel-
18 were obtained when the cells were re-stimulated with
anti-CD3 and anti-CD28 antibodies (Figure 1G). To
determine whether Mel-18 is essential only for the initia-
tion of cytokine gene expression or also functions in dif-
ferentiating Th1 and Th2 cells, the cells were transduced
with the lentiviral shRNAs 48 hours after the first stimu-
lation; the results were comparable (data not shown).
Given our previous data showing the inducible and selec-
tive binding pattern of Mel-18 at the signature cytokine
gene loci in Th1 and Th2 cells [25], the above results
suggest that Mel-18 can function unconventionally as
transcriptional activator of Ifng in Th1 cells and of Il4 in
Th2 cells. Other cytokine genes, such as Tnfa, Il5,a n d
Il10, may also be direct targets of Mel-18.
Mel-18 has a dual function in Th cells
We next aimed to test whether Hoxa7 is a direct target
of Mel-18 in Th cells. The Hoxa7 mRNA level was high
in normal naive cells and decreased after first stimula-
tion and again after re-stimulation (Figure 2A). This
pattern was the opposite to the pattern of cytokine gene
expression. The expression of Hoxa7 was higher in Th2
cells than in Th1 cells, but the dynamic was similar.
ChIP experiments confirmed that Mel-18 bound directly
to the promoter region of Hoxa7 in Th2 cells (Figure
2B), and to a lesser extent, in Th1 cells (data not
shown). The binding was induced following re-stimula-
tion, as at the cytokine genes.
Since Mel-18 positively regulates the expression of
cytokine genes and negatively of Hoxa7, it may function
as both a transcriptional activator and repressor in Th
cells, in a gene-specific manner. We previously observed
some low binding activity of the PcG proteins at the
opposing hallmark cytokine genes [25], and we asked
whether Mel-18 represses their expression. The knock-
down of Mel-18 concomitant with the first stimulation
did not elevate the expression of Ifng in Th2 cells,
which stayed low (data not shown). In contrast, the level
of Tbx21 was increased in Th2 cells by ~1.5- 2-fold fol-
lowing downregulation of Mel-18 (Figure 2C). Mel-18
bound to the Tbx21 promoter in 1 hr re-stimulated Th1
cells, but its binding activity was much stronger in re-
stimulated Th2 cells (Figure2 D ) .T h u s ,t h ee x p r e s s i o n
of Tbx21 in Th2 cells was possibly repressed directly by
Mel-18. All together these results suggest that Mel-18
plays a bi-functional role in Th cells.
The levels of Il4, Il5, and Il13 and of both Gata3 tran-
scripts, were almost unaffected in Th1 cells (data not
shown). In contrast to its binding pattern at Tbx21,
Mel-18 was bound to the Gata3 promoters in
correlation with gene expression, in Th2 and not in Th1
cells (Figure 2E). These results suggest that Mel-18 is
not involved in the transcriptional silencing of Gata3 in
Th1 cells, but it is possible that a more severe downre-
gulation of Mel-18 is necessary to reveal its effect on
Gata3 expression in Th2 cells, as in Mel-18 deficient
mice [54].
Mel-18 knockdown resulted in ~20-50% of live cells
compared to the control (Figure 2F), thus, in Th cells
Mel-18 most likely regulates the expression of additional
genes regulating proliferation or cell survival.
Eed and Ring1A positively regulate the expression of the
hallmark cytokine genes in Th cells
We next investigated the function of the PRC2 protein,
Ezh2, which also binds to cytokine gene promoters
selectively in Th cells [25]. The knockdown of Ezh2 in
Th2 cells resulted in decreased expression of Il4,h o w -
ever, in Th1 cells the expression of Ifng, was unchanged
(data not shown). At present, we do not know whether
the knockdown was insufficient to reveal an effect, or
whether Ezh2 is unnecessary for the transcription of
Ifng in developing Th1 cells. Alternatively, Ezh2 function
is partially redundant with Ezh1 [55,56].
To determine whether other PRC2 proteins regulate
cytokine gene expression in Th1 cells, we repeated the
experiments using shRNAs directed to Eed. Eed, as
other PcG proteins, binds differentially to Il4 and Ifng
promoters, in correlation with gene expression [25]. Eed
is necessary for the histone lysine methyltransferase
activity of Ezh2, and also for the propagation of the
H3K27me3 mark [57,58]. The pattern of Eed mRNA
expression in Th cells (Figure 3A) was similar to that of
Mel-18 mRNA (Figure 1A).
Three different shRNAs knocked Eed down to ~40-
50% in Th1 cells and reduced the expression of Ifng to
the same extent; in contrast, the expression of Tbx21
was unchanged, and that of Hoxa7 increased (Figure 3B,
left panel). Similarly, in Th2 cells, three different
shRNAs knocked Eed down and consequently the
expression of Il4 was decreased, but not that of Gata3
(1b), at least with two of the shRNAs (Figure 3B, right
panel). The expression of Hoxa7 was always higher fol-
lowing Eed knockdown, but the results in some cases
are not considered statistically significant because of
large differences in the extent of the upregulation (For
example, downregulation of Eed with shRNA (Ee3),
increased the expression of Hoxa7 mRNA by 1.51, 4.28,
5.34, and 1.55 in four different experiments). The
decreased expression of Eed protein was confirmed (Fig-
u r e3 C ) ,a sw e l la so fI F N g and IL-4 (Figure 3D). These
results indicate that PRC2 components are necessary for
the expression of the signature cytokine genes in devel-
oping Th1 and Th2 cells.
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Figure 2 Bi-functional role of Mel-18. (A) Quantitative RT-PCR for Hoxa7 as described in Figure 1A. (B) ChIP experiment assessing the relative
binding of Mel-18 at the Hoxa7 promoter region in resting and re-stimulated (P+I), 6-day-differentiated Th2 cells. The binding activity in 1-hr re-
stimulated cells was set as 1. (C) Quantitative RT-PCR for Tbx21 mRNAs following the knockdown of Mel-18 as described in Figure 1B. The
expression level of the control in Th2 cells was set as 1. (D) ChIP experiment assessing the binding of Mel-18 at the Tbx21 promoter in resting
and re-stimulated (P+I), 6-day-differentiated Th1 and Th2 cells. The binding activity in 1-hr re-stimulated Th2 cells was set as 1. (E) ChIP
experiment assessing the binding of Mel-18 at the Gata3 proximal promoter in resting and re-stimulated (P+I), 6-day-differentiated, Th1 and Th2
cells. The binding activity in 1-hr re-stimulated Th2 cells was set as 1. Similar results were obtained with the distal promoter. (F) The number of
live cells on the 5
th day after Mel-18 knockdown relative to the control that was set as 1. The results in Figure 2 are the mean of two or three
independent experiments +S.D.
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Page 7 of 16The PRC1 complex contains also Ring1A, which binds
the cytokine genes in correlation with their expression
[25]. Ring1B catalyzes the ubiquitination of histone H2A
(H2AK119ub1), while both Ring1A and Ring1B contri-
bute to this activity in vivo [59-61]. This modification
can repress gene expression by maintaining RNA poly-
merase II at poised configuration [36]. The pattern of
Ring1A expression resembled those of the other PcG
proteins, although its relative level was higher in naive
cells (Figure 4A). The knockdown of Ring1A in Th1 and
Th2 cells with each one of three different shRNAs
downregulated its expression approximately by half
(Figure 4B). Accordingly, the expression of Ifng in Th1
and Il4 in Th2 cells was reduced in a similar degree, but
that of the lineage-specifying transcription factors was
not. The expression of Hoxa7 was increased in both
Th1 and Th2 cells with most of the shRNAs. Decreased
amounts of the protein Ring1A and of the proteins IFNg
and IL-4 was also observed (Figure 4 C,D). The knock-
down of Eed or Ring1A, like that of Mel-18, reduced
the number of live cells (data not shown). Under these
conditions, none of the signature cytokines or tissue-
specifying transcription factors was derepressed in the
opposing lineage following the knockdown of Eed or
Ring1A (data not shown). Taken together, our results
show that PcG proteins from two different complexes
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Figure 3 Knockdown of Eed downregulates the expression of cytokine genes in primary Th1 and Th2 cells. (A) Quantitative RT-PCR for
Eed, as described in Figure 1A. (B) Quantitative RT-PCR for the indicated mRNAs after Eed knockdown in Th1 (left) and Th2 (right) cells with Eed-
directed shRNAs Ee1, Ee2 and Ee3 or non-silencing scrambled shRNA as a control. The cells were transduced on day 0 and re-stimulated on the
5
th day (aCD3 and aCD28) for 2 hours. The results are presented relative to the control, defined as 1. Differences between knockdown and
control with p values ≤ 0.05 are indicated with an asterisk. C. Western blot for Eed for the indicated transduced Th1 and Th2 cells following
knockdown of Eed. D. ELISA for the levels of IFNg and IL-4 in the supernatants of 2-hour-stimulated (aCD3 and aCD28) Th1 and Th2 cells,
respectively, after Eed knockdown. The results with control shRNA were set as 1. The results in Figure 3 are the mean of three to five
independent experiments +S.D., except in panel 3C, which is a representative experiment.
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Page 8 of 16positively regulate the expression of the hallmark cyto-
kine genes in Th1 and Th2 cells.
PcG proteins positively regulate the expression of
cytokine genes in established Th cells
Since the PcG proteins are well known for their role in
maintaining epigenetic states (although in association
with gene silencing), we examined their effect on cyto-
kine gene expression in established Th cells, using the
murine D5 (Th1) and D10 (Th2) clones. Mel-18 bound
to Ifng and Il4 genes in D5 and D10 cells in correlation
with their expression, as in primary Th1 and Th2 cells
(Figure 5A). In D5 cells, Mel-18 mRNA was knocked
down to ~50% (Figure 5B, left panel), and Mel-18 pro-
tein was reduced as well (Figure 5C). The level of the
Ifng mRNA varied; it was reduced to about half in some
experiments and unchanged in others (for example, the
results for shRNA (M1) were: 0.62, 0.53, 0.52, 1.07, 1.19,
0.97). The knockdown was probably not efficient
enough to consistently reduce the mRNA levels,
especially since D5 cells express high levels of Mel-18
mRNA (Figure 5D). The levels of the Tbx21 and NFAT1
mRNAs were basically unaffected. The D5 cells
expressed very low amounts of Hoxa7 mRNA (data not
shown). In D10 cells, the expression of Mel-18 mRNA
and protein were reduced by ~50% (Figure 5B, right
panel and Figure 5C), and consequently, the Il4 mRNA
level was diminished. The level of Gata3(1a) was
reduced moderately with two shRNAs, and those of
Gata3(1b) and NFAT were almost unchanged. In con-
trast to primary Th2 cells, the level of Hoxa7 was simi-
lar to the control, suggesting that in committed cells the
expression of this gene is repressed by other, probably
more permanent mechanisms.
T h eb i n d i n go fE z h 2a tt h ec y t o k i n ep r o m o t e r si n
stimulated D5 and D10 cells was also differential (Fig-
ure 6A), although not as strong as of Mel-18. Knock-
down of Ezh2 mRNA (Figure 6B) and consequently of
Ezh2 protein (Figure 6C), resulted in lower amounts of
Ifng and Il4 mRNAs in D5 and D10 cells, respectively.
0.5
1
1.5
2
Ring1A
Naive
d2
d6
d8 rest
d8 1h
d8 2h
R
e
l
a
t
i
v
e
 
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
Th1
Th2
R
e
l
a
t
i
v
e
 
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
0.5
1
1.5
2
2.5
3
3.5
4
4.5
Ring1A
Ifng
Tbx21
Hoxa7
Th1
*
* * *
*
*
*
shRNA(R1)
shRNA(R2)
shRNA(R3)
Th2
R
e
l
a
t
i
v
e
 
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
0.5
1
1.5
2
2.5
3
Ring1A Il4
Gata3(1b)
Hoxa7
*
* *
* * *
*
*
*
*
AB
C
D
0.5
1
IFNJ IL-4
R
e
l
a
t
i
v
e
 
p
r
o
t
e
i
n
 
l
e
v
e
l
shRNA(R1)
shRNA(R2)
shRNA(R3)
D-Tubulin
Ring1A
C R1 R2 CC C R1 R2
Th1 Th2
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obtained with primary Th1 cells, and perhaps reflects
the low Ezh2 mRNA level in these cells (Figure 6D),
which may have caused the knockdown to have a
greater impact. Alternatively, the difference may be
related to the differentiation stage or to the possibility
that Ezh2 is necessary to propagate the epigenetic state
during cell cycle, and therefore a longer-term experi-
ment was required to observe an effect. All together,
these results demonstrate that PcG proteins are
necessary for the expression of the signature cytokine
genes, even in committed Th cells.
Mel-18 is required for the binding of NFAT1 and T-bet to
the Ifng promoter
To examine the mechanisms underlying PcG function,
we next characterized the state of the Ifng promoter in
Mel-18-knockdown cells. These experiments were done
using D5 cells, since their proliferation was less sensitive
to the downregulation of Mel-18 after 3-4 weeks of
selection, compared with D10 cells (Figure 7A). The
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Figure 5 Mel-18 is a positive regulator of cytokine genes in D5 and D10 cells. (A) ChIP experiment assessing the binding of Mel-18 at the
Ifng (left) and Il4 (right) promoters in D5 and D10 cells. The cells were stimulated with antigen-presenting cells (APCs) with the appropriate
peptides, cultured for 2-3 weeks, and then left unstimulated or were re-stimulated (P+I) for the indicated time points. In the panel of the Ifng
promoter the result of 1 hr stimulation of D5 cells was set as 1, and in the Il4 promoter panel the result of 1 hr stimulation in D10 was set as 1.
(B) Quantitative RT-PCR for the indicated mRNAs following Mel-18 knockdown in D5 (left) and D10 (right) cells. The cells were re-stimulated with
APCs with the appropriate peptides, transduced with lentiviral shRNAs, cultured in the presence of puromycin for 2-3 weeks, and then re-
stimulated with anti-CD3 and anti-CD28 antibodies for 2 hours. The results are presented relative to the control, defined as 1. Differences
between knockdown and control with p values ≤ 0.05 are indicated with an asterisk (C) Intracellular staining of Mel-18 in the indicated
transduced D5 and D10 cells. (D) Quantitative RT-PCR for Mel-18 in resting and 2-hour-restimulated cells as indicated. The expression level in
resting Th1 cells was set as 1. The results in Figure 5 are the mean of three to six independent experiments +S.D., except panel 5C, which is a
representative experiment.
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decreased the Ifng expression following re-stimulation
with P+I, similar to but more consistent than that
observed following re-stimulation with anti-CD3 and
anti-CD28 antibodies (Figures 7B and 5B). A ChIP
experiment demonstrated that, as expected, the downre-
gulation of Mel-18 diminished significantly its binding
to the Ifng promoter, but as a result also the binding of
the transcription factors NFAT1 and T-bet (Figure 7C).
This was probably a specific effect and not a general
change in the locus accessibility, because the binding of
the PcG protein YY1 was unaffected. The binding of
Ezh2 was not significantly reduced either. This also did
not reflect changes in the level of NFAT1 or T-bet
(Figure 7D), as although the level of T-bet mRNA
decreased moderately (Figure 7B), almost no change was
detectable at the protein level.
The binding of Mel-18 at the Ifng promoter was abol-
ished in D5 cells in the presence of Cyclosporin A
(CsA), which impairs the translocation of NFAT to the
nucleus (Figure 7E). We previously observed similar
results in primary Th cells [25]. In contrast, the binding
activity of Mel-18 at the Hoxa7 promoter region was
unaffected. These results suggest that the binding activ-
ities of the PcG proteins and NFAT are mutually
dependent, and also that the mechanisms for the
recruitment of the PcG proteins differ, depending on
their function.
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Figure 6 Ezh2 is a positive regulator of cytokine genes in D5 and D10 cells. (A) ChIP experiment assessing the binding of Ezh2 at the Ifng
and Il4 promoters in stimulated D5 and D10 cells. In D5 cells the relative binding at the Ifng promoter was set as 1, and in D10 cells the relative
binding to the Il4 promoter was set as 1. (B) Quantitative RT-PCR for the indicated mRNAs following Ezh2 knockdown in D5 (left) and D10 (right)
cells. The cells were re-stimulated (aCD3 and aCD28) for 2 hours. The results are presented relative to the control, defined as 1. Differences
between knockdown and control with p values ≤ 0.05 are indicated with an asterisk. (C) Western blot for Ezh2 for the indicated transduced D5
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ylation of histone 3 (H3K9/14Ac), which is a transcrip-
tional permissive mark (Figure 7C). It is not clear yet
whether this was the cause or the consequence of the
decreased binding activity of T-bet and NFAT. In con-
trast, H3K4me3, which is also a permissive mark, was
stronger. We did not recognize significant changes in
H3K27me3, which was lower at the Ifng promoter than
at the Il4 promoter (Figure 7C and data not shown). We
did not observe a detectable level of H2AK119ub1
before or after Mel-18 knockdown (data not shown).
Taking together these results suggest that the activity of
the PcG proteins as transcriptional activators does not
necessarily involve their classical histone modifications.
Discussion
While the role of the PcG proteins during development
has been extensively studied, there is little information
about their functions in differentiated cells. We used the
RNAi approach to study the functional role of the PcG
proteins in Th cells since the knockout of PRC2 mem-
bers causes embryonic lethality [62]. And although the
PRC1 members, excluding Ring1b, display more redun-
dancy, they have a pivotal role during hematopoiesis
[24,44,45].
Mel-18 deficient mice have severe proliferative defects
in lymphoid cells resulting in hypoplasia of spleen and
thymus [44,63,64], and have less than 5% of the thymo-
cytes of wild-type mice [65]. The differentiation of Mel-
18-deficient Th2 cells is impaired, but not of Th1 [54].
It is possible that the absence of Mel-18 during T cell
development interferes selectively with Th2 differentia-
tion. The expression of Gata3 is reduced in cells derived
from Mel-18-deficient mice [54], and - apart from the
fact that GATA3 is important for T cell development in
the thymus [66] - its early presence may be required for
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Figure 7 Mel-18 is required for the recruitment of T-bet and NFAT to the Ifng promoter in D5 cells.( A )T h en u m b e r so fl i v ec e l l s
following Mel-18 knockdown in D5 and D10 cells relative to the control that was set as 1. (B) Quantitative RT-PCR for the indicated mRNAs in 2-
hour-restimulated (P+I) D5 cells following Mel-18 knockdown (3-4 weeks of selection) with shRNA M1 and control shRNA. The results are
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Page 12 of 16normal subsequent Th differentiation. GATA3, for
example, might be necessary for the initiation of the
intrachromosomal conformation at the Il4 locus [67].
The negative regulation of Tbx21 by Mel-18 in Th2
cells, as we showed, may also explain the modest
enhancement in the expression of IFNg in Th cells
derived from Mel-18-deficient mice.
T cells in general response moderately to the RNAi
procedure [68], and since the knockdown is partial, our
results probably underestimate the importance of PcG
protein functions in Th cells. Nevertheless, our data
suggest that PcG proteins from two different complexes
can function as transcriptional activators of the signa-
ture cytokine genes in primary Th1 and Th2 cells. We
showed similar results also in primary Th17 cells [69].
And Mel-18 and Ezh2 function as positive regulators of
cytokine genes in established Th1 and Th2 cell lines.
Therefore, PcG proteins may act as a general Th-
machinery that induces the expression or maintains the
permissive epigenetic state of the effector cytokine
genes. The PcG proteins also perform the opposite
activity in Th cells, acting as transcriptional repressors
of Hoxa7 in both lineages, and of Tbx21 in Th2 cells.
We also cannot exclude the possibility that a stronger
downregulation of PcG proteins is necessary to detect
negative regulation of the opposing cytokine genes. The
PcG probably have many other targets in Th cells and
the type of PcG activity might depend on the epigenetic
context, the proteins available at the target genes, and
differential posttranslational modifications. But it is also
possible that discrete PcG complexes or isoforms are
involved.
Since we observed fewer live cells following the
knockdown of Mel-18, Eed, or Ring1A, additional tar-
gets of these PcG proteins in Th cells are probably
genes involved in proliferation or survival. It was shown
that the PcG proteins Bmi-1 and Ring1B modulate
apoptosis of Th2 cells through regulation of Bim and
Noxa genes, respectively [50,70]. However, the lower
cell numbers is probably not the reason for the downre-
gulation in the expression of the cytokine genes based
on several reasons: (i) The expression of the mRNAs of
NFAT and the lineage specifying transcription factors
was in general normal, indicating that the effect on the
cytokine genes was specific and did not reflect a general
impairment in lineage differentiation or gene expression;
(ii) There was no correlation between the potential of
specific shRNAs to reduce the expression of cytokines
and their effect on cell numbers; shRNA(M2) directed
to Mel-18 reduced the cell numbers more efficiently
than shRNA(M1), but both presented similar efficiencies
in downregulating cytokine gene expression; (iii) knock
down of Ezh2 in Th17 cells [69], and with some
shRNAs in Th1 and Th2 cells (data not shown) did not
result in diminished cell numbers, but yet downregu-
lated cytokine gene expression.
Because the PcG proteins are well known as transcrip-
tional silencers, one possible explanation for our results
is that the PcG proteins positively regulate the expres-
sion of the cytokine genes indirectly, by repressing a
repressor(s). However, it is more likely that the PcG
proteins function as genuine transcriptional activators of
cytokine genes for the following reasons: (i) The PcG
proteins bind directly, differentially, and inducibly to the
active cytokine genes [25]. It is less plausible that such a
strong correlation is unrelated to their function. More-
over, their binding pattern was dynamic following sti-
mulation, and different PcG proteins bind regulatory
elements of the same gene with differential relative
intensity [25]. Also, the PcG proteins do not bind exclu-
sively active genes; for example, Mel-18 was associated
with Tbx21 in Th2 stronger than in Th1 cells, in asso-
ciation with gene repression. All together these results
strengthen the idea that the binding activity is specific
and does not reflect irrelevant ‘stickiness’ to accessible
DNA; (ii) Several studies in Drosophila and in mamma-
lian embryonic stem cells reported that 10-20% of the
PcG targets were transcriptionally active; therefore, the
binding of PcG proteins does not necessarily lead to
silencing (reviewed in [43]). Moreover, in a human
colon cell line, Suz12 and Ezh2 were associated with the
promoters of several genes that were downregulated
upon Suz12 depletion [71]. In addition, Ezh2 (but not
other PcG proteins) was found as a transcriptional acti-
vator of c-Myc and cyclin D1 in a breast cancer cell line
[72]. The dual function of the PcG proteins may be a
dominant feature of more-committed cells, but possibly
exists in other developmental stages as well.
Recently, Th cells were shown to exhibit more plasti-
city than it was previously appreciated [3,5-12]. Th17
cells exhibit the highest degree of flexibility, even at a
late developmental stage, in the absence of polarizing
cytokines [73]. However, viral infection can reprogram
also Th2 cells in vivo into a Th2-Th1 cells expressing
GATA3 and T-bet simultaneously [74]. Whereas Tbx21
in Th1 cells and Gata3 in Th2 cells are marked selec-
tively with the permissive H3K4me3 and not with the
repressive H3K27me3, in the opposing lineage and in
Th17 cells, these genes are marked bivalently [75], like
the transcriptional regulator genes during embryonic
development. This is considered as a “poised” gene sta-
tus, with the potential for subsequent activation or silen-
cing. Tbx21 was bound more strongly by Mel-18 in Th2
than Th1 cells, in correlation with gene repression.
Indeed its expression was derepressed in Th2 cells fol-
lowing knockdown of Mel-18. These results suggest that
the PcG proteins may regulate, as transcriptional activa-
tors or repressors, gene networks that specify the
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not increased following the knockdown of Mel-18 in
Th1 cells, and it is possible therefore that it is silenced
by other, more stable, mechanisms, or that the knock-
down strength was not sufficient to observe this effect.
We found that PcG proteins were necessary during
early Th differentiation and in established Th cell lines.
They were bound under resting conditions, but their
binding activity was increased following TCR stimula-
tion, in correlation with the inducible expression of the
cytokines (here and [25]). Therefore, they might func-
tion as either: (i) acute transcription factors similar to
NFAT or even as co-factors; (ii) epigenetic regulators
that inducibly increase their binding activity to propa-
gate the transcriptional status during cell duplication,
which normally follows stimulation. They may cooperate
with other chromatin remodeling factors such as BRG1,
which is also recruited in a selective and partially indu-
cible manner to the cytokine genes Ifng in Th1 [76] and
Il4 in Th2 cells [77,78]. Also they may interact with
trithorax group proteins such as MLL that was found to
be essential for the ability of Th2 memory cells to
express the Th2 cytokines [79].
In Th2 cells, the expression level of the GATA3 pro-
tein was decreased following Mel-18 knockdown. How-
ever, stabilization of the lineage specifying
transcription factors cannot be the only mechanism by
which the PcG proteins regulate cytokine gene expres-
sion. For example, the level of GATA3 was essentially
unchanged following the knockdown of Ezh2 in Th2
cells (data not shown), but the expression of Il4
mRNA was reduced. Similarly, the expression of T-bet
was unchanged in Th1 and D5 cells following the
knockdown of Mel-18, but the expression of Ifng
mRNA was downregulated.
What are the relative functional roles of the lineage
specifying transcription factors, TCR-inducible tran-
scription factors and the epigenetic machinery in the
potential network that maintains the transcriptional pro-
grams in Th cells? The restricted recruitment of the
generally expressed PcG proteins is probably regulated
directly or indirectly by the selectively expressed line-
age-specifying transcription factors. The targeting of the
PcG proteins to the cytokine genes is also most likely
NFAT-dependent since we found that impaired translo-
cation of NFAT to the nucleus abrogates the binding of
PcG proteins at the cytokine genes in primary [25] and
established Th cell lines (here and data not shown). It is
possible that NFAT is directly involved in the recruit-
ment of these PcG proteins, and the same mechanisms
that restrict the binding of NFAT [4], dictate the selec-
tive targeting of PcG proteins.
Conversely, we also showed that in an established Th1
cell line Mel-18 was necessary for the recruitment of T-
bet and NFAT1 to the Ifng promoter. Therefore, the
binding activities of the PcG proteins and of NFAT are
mutually dependent. The binding activities of the PcG
proteins and the lineage-specifying transcription factors
can also be interrelated. The PcG proteins in general do
not have sequence-specific binding sites, but they may
stabilize the binding of these transcription factors on
the chromatin. They may also have an indirect effect by
affecting chromatin accessibility, although it must be
specific since the association of YY1 was unchanged.
Instead, PcG proteins can regulate the expression of fac-
tors that are necessary for the binding activity of T-bet
and NFAT.
The lineage specifying transcription factors are not
necessarily associated with the PcG proteins, but both
types of factors can take functional turns in a way that
t h eb i n d i n go fe a c ho ft h e mi sap r e r e q u i s i t ef o rt h e
binding of the other one. The lineage-specifying tran-
scription factors may specify the binding sites for the
general machinery, which on its turn facilitates the her-
itability of the epigenetic programs during mitosis, and
by that assists the re-establishment of the specific fac-
tors. Absence of the specific factors that re-enforce the
selective recruitment of the general maintenance
machinery, may result in progressive dilution of epige-
netic marks during mitosis, and consequently impaired
the accessibility of the lineage specifying transcription
factors to their target genes.
Conclusions
Our results show that PcG proteins have a dual function
in Th cells as positive and negative regulators of gene
expression. Our results also suggest that both activities
can results from a direct effect. The lineage-dependent
recruitment of the PcG proteins and consequently their
restricted regulation of the effector cytokine genes have
a potential for therapeutic applications. The expression
of Ezh2 mRNA is significantly downregulated in patients
with active systemic lupus erythematosus [80], which
could be one of the reasons for their abnormal cytokine
production.
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